Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges

被引:0
作者
Pamela E. Macintyre
Lindy J. Roberts
Christine A. Huxtable
机构
[1] Royal Adelaide Hospital,Acute Pain Service, Department of Anaesthesia, Pain Medicine and Hyperbaric Medicine
[2] University of Adelaide,Discipline of Acute Care Medicine
[3] Sir Charles Gairdner Hospital,Departments of Anaesthesia and Pain Management
来源
Drugs | 2020年 / 80卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
For over two decades, dramatic increases in opioid prescriptions in the developed world, especially for long-term management of chronic noncancer pain, were accompanied by increases in patient harm. In recent years in the USA, opioid-related deaths rates have continued to increase despite falls in prescribing rates and deaths associated with prescription opioids. In large part, this is attributed to the growing availability of illicitly manufactured fentanyl. Increased opioid use, for medical and nonmedical reasons, has led to more opioid-tolerant patients requiring management of acute pain. The potential harms associated with long-term opioid use are now well known. What may be less well understood is that preoperative long-term opioid use is associated with increased perioperative complications including infection, readmissions, and greater healthcare utilisation and costs. Minimizing opioid use prior to surgery is a modifiable risk factor that could benefit both patient and healthcare system. Management of acute pain should include simple analgesics and adjuvants, with short-term opioid dose increases if needed and use of non-pharmacological strategies. Reported pain intensities may be high and titration of analgesia to function rather than pain scores is appropriate. Importantly, compared with opioid-naïve patients, opioid-tolerant patients may be at higher risk of opioid-induced ventilatory impairment when additional opioids are administered to manage new acute pain. For some patients, perioperative care may be best coordinated by a perioperative or post-discharge service with referral to multidisciplinary pain and addiction medicine services as indicated. Carefully planned and communicated discharge prescribing, with a weaning plan for additional opioids, is essential.
引用
收藏
页码:9 / 21
页数:12
相关论文
共 665 条
[1]  
Busse JW(2018)Opioids for chronic noncancer pain: a systematic review and meta-analysis JAMA 320 2448-2460
[2]  
Wang L(2017)Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions Anesth Analg 125 1769-1778
[3]  
Kamaleldin M(2017)High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews Cochrane Database Syst Rev 10 CD012299-576
[4]  
Craigie S(2015)Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis Pain 156 569-697
[5]  
Riva JJ(2015)Frequency, predictors, and medical record documentation of chemical coping among advanced cancer patients Oncologist. 20 692-276
[6]  
Montoya L(2018)Substance Use disorder among current cancer patients: rates and correlates nationally in the department of veterans affairs Psychosomatics. 59 267-859
[7]  
Ballantyne JC(2019)A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis Pain 160 852-512
[8]  
Els C(2018)Trends in opioid utilisation in Australia, 2006-2015: insights from multiple metrics Pharmacoepidemiol Drug Saf 27 504-1355
[9]  
Jackson TD(2018)Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: a primary care data linkage study Br J Anaesth 120 1345-e82
[10]  
Hagtvedt R(2019)The opioid death crisis in Canada: crucial lessons for public health Lancet Public Health. 4 e81-267